CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY
Clinical trials for CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY explained in plain language.
Never miss a new study
Get alerted when new CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY trials appear
Sign up with your email to follow new studies for CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New CIDP drug shows promise in early trial
Disease control CompletedThis study tested a new drug called SAR445088 in 98 adults with CIDP, a nerve disorder that causes weakness and numbness. The goal was to see if the drug could help control the disease in people who are on standard treatment, have not responded to standard treatment, or have neve…
Matched conditions: CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY
Phase: PHASE2 • Sponsor: Bioverativ, a Sanofi company • Aim: Disease control
Last updated May 26, 2026 03:55 UTC
-
Blood test may help personalize nerve disease treatment
Knowledge-focused CompletedThis study examined 20 adults with chronic nerve conditions (CIDP or MMN) to see if changes in IgG levels after their first IVIg treatment could predict the long-term dose they need. Researchers aimed to find a faster, more precise way to adjust treatment, reducing side effects a…
Matched conditions: CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY
Sponsor: Walton Centre NHS Foundation Trust • Aim: Knowledge-focused
Last updated May 22, 2026 14:04 UTC